Skip to content

Total debt at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$987.3M-28.4%
Revvity logo
RevvityRVTY
$3.94B+17.8%
Opko Health logo
Opko HealthOPK
$52.78M-4.2%
Abbott logo
AbbottABT
Danaher logo
DanaherDHR
Quest Diagnostics logo
Quest DiagnosticsDGX

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$832.61M-56.1%
Enterprise value$3.8B-22.0%
P/S0.3×-0.4×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Calculated from QuidelOrtho Corporation’s reported figures.

Plus components not separately reported this period.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's total debt?
QuidelOrtho Corporation (QDEL) reported total debt of $3.1B in Q1 2026.
How has QuidelOrtho Corporation's total debt changed year-over-year?
QuidelOrtho Corporation's total debt increased by 0.3% year-over-year, from $3.09B to $3.1B.
What is the long-term trend for QuidelOrtho Corporation's total debt?
Over 4 years (2021 to 2025), QuidelOrtho Corporation's total debt has grown at a 115.4% compound annual growth rate (CAGR), from $140M to $3.01B.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.